Zobrazeno 1 - 10
of 30
pro vyhledávání: '"A. G. Christina Bergqvist"'
Autor:
Sue Groveman, Joerg Klepper, Klaus‐Peter Liesenkötter, Adda Grimberg, A. G. Christina Bergqvist
Publikováno v:
Epilepsia Open, Vol 9, Iss 3, Pp 1096-1102 (2024)
Abstract The ketogenic diet (KD) can have a negative impact on the linear growth and body composition of children. The aims of this study were to review two centers' experience with children who developed height deceleration on the KD and determine i
Externí odkaz:
https://doaj.org/article/2fb5bb6c730b419db2ee89a93a4968b7
Publikováno v:
Nutrition in Clinical Practice. 38:465-466
Publikováno v:
Seizure. 80:242-248
The ketogenic diet (KD) is initiated emergently in the intensive care unit (ICU) for patients with super refractory status epilepticus (SRSE) and epileptic encephalopathies (EE). However, few data are available regarding safety, effectiveness, and lo
Autor:
Matthew's Friends, Danielle A.J.E. Lambrechts, Elaine C. Wirrell, James W. Wheless, Rana S. Jehle, Eric H. Kossoff, Stéphane Auvin, Douglas R. Nordli, Orkide Güzel, Karen Ballaban-Gil, Joerg Klepper, Janak K. Nathan, Heidi H. Pfeifer, Y.M. Christiana Liu, Ingrid E. Scheffer, Carl E. Stafstrom, Elles J.T.M. van der Louw, Roberto Caraballo, Maria Dahlin, A. G. Christina Bergqvist, J. Helen Cross, Beth Zupec-Kania, Robyn Blackford, Jong M. Rho, Suvasini Sharma, María Vaccarezza, Elizabeth A. Thiele, Hoon Chul Kang, Jeffrey Buchhalter, Pierangelo Veggiotti, Zahava Turner, Elizabeth J. Donner
Publikováno v:
Epilepsia Open
Epilepsia Open, 3(2), 175-192. Wiley-Blackwell Publishing Ltd
Epilepsia Open, 3(2), 175-192. Wiley-Blackwell Publishing Ltd
Summary Ketogenic dietary therapies (KDTs) are established, effective nonpharmacologic treatments for intractable childhood epilepsy. For many years KDTs were implemented differently throughout the world due to lack of consistent protocols. In 2009,
Autor:
J Nicholas Brenton, Diana Lehner-Gulotta, Emma Woolbright, Brenda Banwell, A G Christina Bergqvist, Shanshan Chen, Rachael Coleman, Mark Conaway, Myla D Goldman
Publikováno v:
J Neurol Neurosurg Psychiatry
BackgroundDietary changes impact human physiology and immune function and have potential as therapeutic strategies.ObjectiveAssess the tolerability of a ketogenic diet (KD) in patients with relapsing multiple sclerosis (MS) and define the impact on l
Autor:
A. G. Christina Bergqvist, Katherine L. Helbig, Suzanne D. DeBrosse, Ethan M. Goldberg, Tariq Zaman, Livija Medne, Ivana Babić Božović, Aleš Maver, Kimberly Wallis, Borut Peterlin, Xiaohong Zhang, Ingo Helbig
Publikováno v:
Annals of Neurology. 83:703-717
Objective Voltage-gated sodium (Na+) channels underlie action potential generation and propagation and hence are central to the regulation of excitability in the nervous system. Mutations in the genes SCN1A, SCN2A, and SCN8A, encoding the Na+ channel
Publikováno v:
Journal of child neurology. 34(14)
Treatment-resistant epilepsy affects 30% of children with epilepsy and results in significantly reduced quality of life. The ketogenic diets offer a chance for significant seizure reduction and seizure freedom. Compliance is strongly linked to the ef
Autor:
Myla D. Goldman, Rachael Coleman, Emily Leytham, Diana Lehner-Gulotta, Brenda Banwell, A. G. Christina Bergqvist, J. Nicholas Brenton, Lauren Gampper
Publikováno v:
Neurology® Neuroimmunology & Neuroinflammation
ObjectiveTo assess the safety and tolerability of a modified Atkins diet (KDMAD), a type of ketogenic diet (KD), in subjects with relapsing MS while exploring potential benefits of KDs in MS.MethodsTwenty subjects with relapsing MS enrolled into a 6-
Publikováno v:
ICAN: Infant, Child, & Adolescent Nutrition. 7:342-346
Breastfeeding continues to be the recommended mode of infant feeding with numerous nutritive and nonnutritive benefits to both mothers and babies. The ketogenic diet (KD) is a high-fat, adequate protein, and very low carbohydrate diet prescribed for
Publikováno v:
ICAN: Infant, Child, & Adolescent Nutrition. 7:157-161
Objective. The ketogenic diet (KD) can result in hyperlipidemias. We report improvements in the lipid profiles of 3 children who were switched from KetoCal 4:1 powder (formulation prior to fall 2013) to KetoCal 4:1 Liquid formula. Compared with the K